INTRODUCTION
Malignant renal tumours were described as early as 1826 when Knoig reported 2 patients with modullary sarcoma of the kidney. 1 In 1855, Robin had concluded that renal carcinoma arose from renal tubular epithelium. This interpretation was confirmed by Waldeyer in 1867.
Unfortunately, theoretical and practical considerations of renal tumors were confused by Gravitz, who contended that such apparent renal tumour arose from adrenal rests within the kidney. He introduced the terminology "Struma lipomatodes aberrata renis" as descriptive nomenclature for the tumours of clear cells that he believed were derived from the adrenal gland.
In 1894 Lubarch endorsed the idea of these being a suprarenal original tumour, and the term "hypernephroid tumors" indicating origin above the kidney was advocated by Birch-Hirschfeld. It was this semantic and conceptual mistake that led to the introduction of the term "hypernephroma", which predominates in the literature describing parenchymal tumors of the primary renal origin.
Some classification of the histopathology of renal tumors is derived from the work of Albanan and Imbert and the four volume contribution of Walf written between 1883 to 1928, adds further historical significance to our understanding of renal tumours today. 2 The first planned nephrectomy for renal tumors was performed by Gustav Simon, the operation has undergone several modifications concerning the approach as well as the extent. Recently, radical nephrectomy which includes the dissection and early ligation of renal vein and artery, in addition to lymphadenectomy if necessary has been gaining ground (Robson).
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METHODS
Present study was retrospective as well as prospective study and was carried out in the Department of Surgery, Government Medical College and Hospital, Auragnabad for a period of one year Retrospective study was done from the record in Radiotherapy Department of this college. Prospective study was done with the number of cases of kidney tumors admitted during the study period. Total number of cases studied were 44, out of these, 26 was studied retrospectively and 18 cases prospectively. Patients who were absconded after admission are also included.
Confirmation of Diagnosis was made with intravenous pyelography in most of the cases, whereas retrograde pyelography in most of the cases, whereas retrograde pyelography and ultrasonography were done in few patients and properly recorded in the proforma.
RESULTS
The youngest patient of renal cell carcinoma was found to be of 35 years, and oldest of 70 years old. The maximum incidence was found in 5th and 6th decade of life. In this treatise, maximum number of cases was presented with lump in abdomen (78.27%), and classic triad of pain, lump and hematuria was only in 4 cases (17.40%). Maximum number of patients was in stage III and IV.
Staging of renal cell carcinoma was done according to Robsons staging proposed by Holland. Most commony used treatment modality in our patients was Nephrectomy + RT + CT + HT in 9 cases (39.13%).
Chemotherapeuticagent used in our patient was inj. Vinblastine in the dose of 0.2 mg/kg, 2 weekly for 6 doses. Harmonal therapy was given which injection medroxyprogesteron 1000 mg once a week for 3 months.
Local radiotherapy was given in the dose of 4000 rade to 5000 rads in 10-15 fractions.
In 3 patients no any treatment was given because they are expired or absconded before any intervention.
DISCUSSION
In our study maximum cases were of renal cell carcinoma i.e. 23 (52.28%). In the series of Bennington (1973 Incidence of renal cell carcinoma in male was found to be more than female with male:female ratio of 2:1, in the number of series. de-kernion JB 5 , Rafla S 1 and Boxer R et al 6 found male:female ratio to be 2.2:1. We found male:female ratio 1.3:1, thus approximately equal incidence compared with afore mentioned series.
Our observation is that the renal cell carcinoma involves the left kidney more than that of right kidney 60.703 and 39.30% respectively. Other series also noted equal incidence on both side. It shows that there is no specific side predilection for renal tumour.
Bilateral involvement by renal cell carcinoma is rare entity. Out of 23 cases of renal cell carcinoma, we had not a single case of bilateral involvement.
Kantor
2 noted the high incidence of renal cell carcinoma in men who smoke pipe or cigars. Bennington and Labscher found that risk of developing renal cell carcinoma was found to be over 5 times higher in men who used any form of tobacco than those who did not use tobacco. 3 They also observed that the risk is higher amongst those who are smoking pipes and/or cigars. Lemerly 8 found high incidence of renal cell carcinoma in inflammatory conditions of kidney, where crystalline ester cholesterol got deposited and stimulated the development of cortical adenomas and continued neoplastic growth.
In our study, we found the etiological factors for renal cell carcinoma, as smoking in 30.50% of the cases and Infection in 0.50% of the cases. In cases of renal pelvic tumours, habit of smoking was found in 71.42% patients, infection in 28.57% of the cases stones in renal pelvis in 57.14% of cases. All cases of squamous cell carcinoma had stone in the renal pelvis.
Abnormal laboratory findings in cases of renal cell carcinoma reported by Skinner DG et al 9 are erythrocytosis in 3% of cases, Hypercalcemia in 3% of the cases. Hypercalcemia in 4.9%, polycythemia in 3.5% of the cases Boxer R et al 6 found raised ESR in 50% of cases of renal cell carcinoma, Hypercalcemia in 12.2% of cases. We found raised ESR in 8.70% of cases but hypercalcemia, abnormal liver function test and Erythrocytosis was not detected in our patients.
CONCLUSION
Male to female ratio in case of renal cell carcinoma is found to be almost equal (1.3:1). Commonest etiological factor for renal cell carcinoma is smoking (30.50% of the cases). Maximum cases of renal cell carcinoma were presented with lump in abdomen and classic triad was found in only 17.4% of cases (i.e. pain, hematuria and lump). Maximum cases of renal cell carcinoma were found to be in stage III and IV. Majority of the renal cell carcinomas were treated with nephrectomy, postoperative radiotherapy, chemotherapy and hormonal therapy in combination. Approximately survival rate of renal cell carcinoma is 17.39%.
